Diallyl Trisulfide Inhibits Leptin-induced Oncogenic Signaling in Human Breast Cancer Cells but Fails to Prevent Chemically-induced Luminal-type Cancer in Rats.

Kim, Su-Hyeong; Hahm, Eun-Ryeong; Singh, Krishna B; Singh, Shivendra V

Kim, Su-Hyeong; Hahm, Eun-Ryeong; Singh, Krishna B; Singh, Shivendra V.

Afiliación

Kim SH; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Hahm ER; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Singh KB; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Singh SV; Department of Pharmacology and Chemical Biology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

J Cancer Prev ; 25(1): 1-12, 2020 Mar 30.

Article en En | MEDLINE | ID: mdl-32266174

Palabras clave

Breast cancer; Chemoprevention; Diallyl trisulfide; Leptin; STAT3

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cancer Prev Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google